Inhibrx Biosciences, Inc. INBX Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s software and technology licenses, net?
- Inhibrx Biosciences, Inc. (INBX) reported software and technology licenses, net of $4.38M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s software and technology licenses, net changed year-over-year?
- Inhibrx Biosciences, Inc.'s software and technology licenses, net decreased by 35.6% year-over-year, from $6.8M to $4.38M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s software and technology licenses, net?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s software and technology licenses, net has grown at a 17.6% compound annual growth rate (CAGR), from $3.16M to $4.38M.